Overview

Wet macular degeneration is a chronic eye disease that causes blurred vision or a blind spot in your visual field. It's generally caused by abnormal blood vessels that leak fluid or blood into the macula (MAK-u-luh). The macula is in the part of the retina responsible for central vision.

Wet macular degeneration is one of two types of age-related macular degeneration. The other type — dry macular degeneration — is more common and less severe. The wet type always begins as the dry type.

Early detection and treatment of wet macular degeneration may help reduce vision loss and, in some instances, recover vision.

Wet macular degeneration care at Mayo Clinic

Dec. 24, 2015
References
  1. AskMayoExpert. Age-related macular degeneration. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  2. Preferred Practice Pattern: Age-related macular degeneration. San Francisco, CA: American Academy of Ophthalmology; 2015. http://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015. Accessed Sept. 22, 2015.
  3. Age-related macular degeneration? American Academy of Ophthalmology. http://www.geteyesmart.org/eyesmart/diseases/amd.cfm. Accessed Sept. 17, 2015.
  4. Facts about age-related macular degeneration. National Eye Institute. http://www.nei.nih.gov/health/maculardegen/armd_facts.asp. Accessed Sept. 17, 2015.
  5. Lawrenson JG, et al. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews. http://ovidsp.tx.ovid.com/sp-3.16.0b/ovidweb.cgi. Accessed Sept. 22, 2015.
  6. Yanoff M, et al., eds. Age-related macular degeneration. In: Ophthalmology. 4th ed. Edinburgh, U.K.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed Sept. 17, 2015.
  7. Ranibizumab. Micromedex. http://www.micromedexsolutions.com. Accessed Oct. 8, 2015.
  8. Garg SJ. Age-related macular degeneration. Merck Manual Professional Version. http://www.merckmanuals.com/professional/eye-disorders/retinal-disorders/age-related-macular-degeneration-amd-or-armd. Accessed Sept. 22, 2015.
  9. Moja L, et al. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews. http://ovidsp.tx.ovid.com/sp-3.17.0a/ovidweb.cgi. Accessed Sept. 22, 2015.
  10. Aflibercept. Micromedex. http://www.micromedexsolutions.com. Accessed Oct. 8, 2015.
  11. Arroyo JG. Age-related macular degeneration: Treatment and prevention. http://www.uptodate.com/home. Accessed Sept. 25, 2015.
  12. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. July 22, 2015.
  13. Garrity J. Structure and function of the eyes. Merck Manual Consumer Version. http://www.merckmanuals.com/home/eye-disorders/biology-of-the-eyes/structure-and-function-of-the-eyes. Accessed Sept. 28, 2015.
  14. Sloan FA, et al. The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration. JAMA Ophthalmology. 2014;132:456.